![]() The average price target represents a 172.45% change from the last price of $0.72. The average price target is $1.96 with a high forecast of $2.35 and a low forecast of $1.49. See Top Rated MarketRank™ Stocks Here About Tonix Pharmaceuticals (NASDAQ:TNXP) StockBased on 4 Wall Street analysts offering 12 month price targets for Jushi Holdings in the last 3 months. Amount of Analyst Coverage Tonix Pharmaceuticals has only been the subject of 1 research reports in the past 90 days. pool table brunswick According to analysts' consensus price target of $12.85, Tonix Pharmaceuticals has a forecasted upside of 989.0% from its current price of $1.18. Not an offer or recommendation by Stocktwits. View real-time stock prices and stock quotes for a full financial overview.Tonix Pharmaceuticals Holding Corp Stock - TNXP Share Price Today, News and Discussion DIA 0.95% SPY 1.90% QQQ 2.89% RUM 7.26% NFLX 8.86% BLUE 4.25% JUP.X 3.56% NUZE 12.89% PTON 5.76% ZYME 3.21% AA 3.77% BOIL 3.12% DFS 4.05% More Advertisement 3rd Party Ad. Whenever you add a symbol to your …TNXP | Complete Tonix Pharmaceuticals Holding Corp. st charles mo arrests Import your watchlist from Stocktwits and get a realtime overview of all news articles published regarding your favorite symbols. Watch list Create TNXP Alert After Hours Last.#TNXP #tnxpstock #tnxpstockprediction #tnxpstockanalysis #TonixPharmaceuticals #nyse #nasdaq #stocks #dowjonesTNXP Stock - Tonix Pharmaceuticals Holding Corp. ![]() 7:00am EST.Stocks United States TNXP Overview Stock Screener Earnings Calendar Sectors Nasdaq | TNXP U.S.: Nasdaq Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals Announces Collaboration with Boston Children's Hospital to Study TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Graft-versus-Host Disease (GvHD) Following Hematopoietic Stem Cell Transplantation in Animals.
0 Comments
Leave a Reply. |